RNAi Drug Delivery: Technologies and Global Markets
Report Scope:
This research report categorizes the market for nucleic acid drugs by type. The major product segments are conjugated and encapsulated. The non-viral vectors used for encapsulation are divided into polymers, lipids and others (e.g., inorganic material, hybrid systems). The market is also segmented based on the molecule types, delivery modes and therapeutic areas. It is divided by application types into therapeutic applications and research-based applications. The markets in North America, Europe, the Asia-Pacific region and Rest of the World (RoW) are covered.
Report Includes:
24 data tables and 45 additional tables
An up-to-date overview and industry analysis of the global markets for RNA interference (RNAi) drug delivery technologies
Analyses of the global market trends, with historic market revenue (sales figures) from 2020 to 2022, estimates for 2023, and projections of compound annual growth rates (CAGRs) through 2028
Estimation of the actual market size and revenue forecast for the RNAi drug delivery technologies market, and corresponding market share analysis based on type of RNAi, therapeutic area, and region
Discussion of major growth drivers, industry-specific challenges, regulatory aspects, and technology advancement that will shape the market for RNAi drug delivery technologies as a basis for projecting demand in the next few years (2023-2028)
Review of key patent grants and patent applications on RNAi drug delivery markets, and emerging technologies and new developments within the marketplace
Latest information on the mergers and acquisition deals, partnerships, agreements, collaborations, and other strategic alliances within the marketplace
Insight into the recent industry structure, competitive aspects of each product segments, increasing investment on R&D activities, market growth strategies, and company revenue share analysis
A look at commercial opportunities in the RNAi research tools and reagents, recent progress and future opportunities for RNAi therapeutics in various disease classifications, clinical trial applications, and potential markets for future developments
Identification of the major stakeholders and analysis of the competitive landscape based on recent developments, segmental revenues, and operational integration
Descriptive company profiles of the leading global players of the industry, including Alnylam Pharmaceuticals, Benitec Biopharma, Ionis Phamaceutical, Novo Nordisk and Sirnaomics Inc.
Companies Mentioned
ALNYLAM PHARMACEUTICALS INC.
ARBUTUS BIOPHARMA CORP.
ARCTURUS THERAPEUTICS INC.
Arrowhead Pharmaceuticals Inc.
BENITEC BIOPHARMA
CELLECTA INC.
Eleven Therapeutics
GENEVANT SCIENCES CORP.
IONIS PHARMACEUTICALS INC.
Mirimus, Inc.
NANODE THERAPEUTICS INC.
NOVO NORDISK
Olix Pharmaceuticals
PHIO PHARMACEUTICALS CORP.
SILENCE THERAPEUTICS PLC
SIRNAOMICS INC.
SOMAGENICS, INC.
- Chapter 1 Introduction
- Study Goals and Objectives
- Reasons for Doing the Study
- Scope of Report
- What's New in This Update?
- Research Methodology
- Geographic Breakdown
- Chapter 2 Summary and Highlights
- Market Outlook
- Chapter 3 Market Overview
- Introduction
- History of Nucleic Acid Drugs
- Antisense Oligonucleotides
- RNA
- Drug Delivery System
- Nucleic Acid Drugs
- Inhibition Type
- Antisense Oligonucleotide
- Regulations
- Pre-Clinical INDA
- COVID-19 Impact Analysis on the RNAi Drug Delivery Markets
- Positive Impact of COVID-19
- Negative Effect of COVID-19
- Chapter 4 Market Dynamics
- Market Drivers
- Approved RNAi Drugs
- Venture Funding Increased in RNAi Drugs
- RNAi Drugs Designated as Orphan Drugs
- New Nanoparticle Technologies for Drug Delivery Systems
- Market Restraints
- High Drug Costs
- Lack of Awareness Regarding Rare Diseases
- Clustered Regularly Interspaced Short Palindromic Repeats Technology Application Growing
- Market Opportunities
- Application in Cancer Treatment
- Infectious Disease and RNAi Drugs
- Chapter 5 Nucleic Acid Drug Delivery Technology Market by Type
- Encapsulation
- Viral Vector-Based
- Non-Viral Vector-Based Delivery System
- Conjugates
- Chapter 6 Market Breakdown by Application
- Drug Development and Discovery
- Process of RNA-Based Drug Discovery
- Design of RNAi Drugs
- Sequence Optimization
- Chemical Modification
- Targeted Delivery
- Therapeutic Application
- Chapter 7 Market Breakdown by Route of Administration
- Chapter 8 Market Breakdown by Molecules
- Small Interfering Ribonucleic Acid
- Antisense Oligonucleotide
- Fomivirsen (Vitravene)
- Mipomersen
- Nusinersen (Spinraza)
- Inotersen (Tegsedi)
- Eteplirsen (Exondys 51)
- Golodirsen (Vyondys 53)
- Milasen: A Unique Personalized Medicine
- Messenger RNA
- Others
- Aptamers
- Micro RNA
- Chapter 9 Market Breakdown by Therapeutic Area
- Oncology
- Rare and Genetic Diseases
- Central Nervous System
- Respiratory
- Other Disease
- Chapter 10 Market Breakdown by Region
- North America
- Europe
- Asia-Pacific
- Japan
- South Korea
- China
- India
- Australia
- Rest of the World
- Chapter 11 Environmental, Social and Governance in the Biotechnology Sector
- Key Environmental, Social and Governance Issues in the Biotechnology Industry
- Biotechnology Industry Environmental, Social and Governance Performance Analysis
- Environmental Performance
- Social Performance
- Governance Performance
- Consumer Perspective on ESG in Biotechnology
- Case Study
- Concluding Remarks from BCC Research
- Chapter 12 Emerging Technologies and Developments
- Drug Delivery to Lungs
- Nanotechnology
- Use of Artificial Intelligence and Machine Learning
- Chapter 13 Clinical Trial and Patent Analysis
- Clinical Trials Analysis
- Patent Analysis
- Chapter 14 Mergers and Acquisitions and Funding Outlook
- Start-Up Funding in Nucleic Acid Delivery Technology
- Chapter 15 Competitive Intelligence
- Chapter 16 Company Profiles
- ALNYLAM PHARMACEUTICALS INC.
- ARCTURUS THERAPEUTICS INC.
- ARBUTUS BIOPHARMA CORP.
- ARROWHEAD PHARMACEUTICALS INC.
- BENITEC BIOPHARMA
- CELLECTA INC.
- ELEVEN THERAPEUTICS
- GENEVANT SCIENCES CORP.
- IONIS PHARMACEUTICALS INC.
- MIRIMUS, INC.
- NOVO NORDISK
- NANODE THERAPEUTICS INC.
- OLIX PHARMACEUTICALS
- PHIO PHARMACEUTICALS CORP.
- SILENCE THERAPEUTICS PLC
- SIRNAOMICS INC.
- SOMAGENICS, INC.
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook